Mise au point et activité biologique d’une crème à base d’huile essentielle de clou de girofle

Abstract

Clove essential oil is isolated from the dried flower buds of Syzygium aromaticum from which many biological activities have been reported. The aim of this work was to develop a cream for topical use containing clove essential oil (HE) as an active ingredient and to test its biological activity. Clove EO was extracted by hydrodistillation, its chemical composition was analysed by Gas chromatography-mass spectrometry (CG-SM). The EO was then incorporated into a cream where its stability was studied. The antifungal activity was evaluated by disc-diffusion method. The in vivo anti-inflammatory activity of EO and the cream was assessed y by carrageenan-induced rat paw edema model. Clove EO contains two major constituents: eugenol (69.14%) and β-Caryophyllene (18.8%). The cream had good organoleptic and physicochemical properties. Both EO and the cream showed growth inhibitory effects on the two studied dermatophytes strains. The incorporation of EO in the cream provided a good anti-inflammatory activity, similar to the reference drug. The developed creme was stable, had good anti-inflammatory properties and moderate antifungal activity. Long-term stability studies and in vivo tests would lead to the use of clove essential oil in the development of new pharmaceutical forms.